Back
Verona Pharma PLC 10K Form
Buy
51
VRNA
Verona Pharma PLC
Last Price:
38.47
Seasonality Move:
15.78%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-02 | 10Q | VRNA/Verona Pharma PLC Quarterly |
| 2023-08-03 | 10Q | VRNA/Verona Pharma PLC Quarterly |
| 2023-05-09 | 10Q | VRNA/Verona Pharma PLC Quarterly |
| 2022-11-09 | 10Q | VRNA/Verona Pharma PLC Quarterly |
| 2022-08-09 | 10Q | VRNA/Verona Pharma PLC Quarterly |
| 2022-05-03 | 10Q | VRNA/Verona Pharma PLC Quarterly |
Receive VRNA News And Ratings
See the #1 stock for the next 7 days that we like better than VRNA
VRNA Financial Statistics
Sales & Book Value
| Annual Sales: | $458K |
|---|---|
| Cash Flow: | $-62.66M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.59 |
| Price / Book: | 24.07 |
Profitability
| EPS (TTM): | -2.00000 |
|---|---|
| Net Income (TTM): | $-153.72M |
| Gross Margin: | $0 |
| Return on Equity: | -74.15% |
| Return on Assets: | -45.04% |
Verona Pharma PLC Earnings Forecast
Key Verona Pharma PLC Financial Ratios
- The Selling, General & Administrative Expenses for VRNA have been equal to 5,803.28% of Gross Profit Margin.
- The Interest Expense is -3.78% of Operating Income.
- Per Share Earnings over the last 19 years have been positive in 9 years.
Verona Pharma PLC Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | VRNA |
| CUSIP: | 925050 |
| Website: | veronapharma.com |
Debt
| Debt-to-Equity Ratio: | 0.92 |
|---|---|
| Current Ratio: | 13.03 |
| Quick Ratio: | 12.47 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
VRNA Technical Analysis vs Fundamental Analysis
Buy
51
Verona Pharma PLC (VRNA)
is a Buy
Is Verona Pharma PLC a Buy or a Sell?
-
Verona Pharma PLC stock is rated a Buy
The current Verona Pharma PLC [VRNA] share price is $38.39. The Score for VRNA is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.